Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery
Phase 2
Completed
- Conditions
- Colorectal Cancer
- Interventions
- Procedure: conventional surgeryRadiation: radiation therapyProcedure: tumor biopsyOther: laboratory biomarker analysis
- First Posted Date
- 2006-06-15
- Last Posted Date
- 2013-03-05
- Lead Sponsor
- Vanderbilt-Ingram Cancer Center
- Target Recruit Count
- 24
- Registration Number
- NCT00336960
- Locations
- ๐บ๐ธ
Veterans Affairs Medical Center - Tennessee Valley Healthcare System - Nashville Campus, Nashville, Tennessee, United States
๐บ๐ธVanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast
Phase 2
Terminated
- Conditions
- Breast Cancer
- First Posted Date
- 2004-05-19
- Last Posted Date
- 2013-02-25
- Lead Sponsor
- Vanderbilt-Ingram Cancer Center
- Target Recruit Count
- 1
- Registration Number
- NCT00082667
- Locations
- ๐บ๐ธ
Meharry Medical College, Nashville, Tennessee, United States
๐บ๐ธVanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung Cancer
Phase 1
Completed
- Conditions
- Lung Cancer
- First Posted Date
- 2004-04-22
- Last Posted Date
- 2013-05-03
- Lead Sponsor
- Vanderbilt-Ingram Cancer Center
- Target Recruit Count
- 6
- Registration Number
- NCT00002519
- Locations
- ๐บ๐ธ
University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States
๐บ๐ธSarah Cannon-Minnie Pearl Cancer Center, Nashville, Tennessee, United States
๐บ๐ธVanderbilt Cancer Center, Nashville, Tennessee, United States
Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast Cancer
Phase 2
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2003-12-24
- Last Posted Date
- 2012-08-14
- Lead Sponsor
- Vanderbilt-Ingram Cancer Center
- Target Recruit Count
- 46
- Registration Number
- NCT00006104
- Locations
- ๐บ๐ธ
Providence Hospital, Mobile, Alabama, United States
๐บ๐ธRobert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
๐บ๐ธEvanston Hospital, Evanston, Illinois, United States